Surgical management can achieve seizure freedom in pediatric patients with drug-resistant epilepsy, but special precautions must be taken.
With FDA approval of EpidiolexR, the pace of research on CBD medication is likely to increase.
A new study shows that cannabidiol is effective in children with Lennox-Gastaut syndrome.
Two studies demonstrate clinically significant response to oral liquid cannabidiol over placebo.
A quality improvement project with relatively simple interventions resulted in a significant decrease in Emergency Department visits and inpatient admissions, while saving $2 million in health care costs.
Surgery proves to be a viable option for patients with medically refractory epilepsy.
